Alpha-synuclein–mediated DNA damage, STING activation, and neuroinflammation in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly spans the biological, physical, and social sciences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“α-synuclein pathology was found to cause STING-dependent neuroinflammation and dopaminergic neurodegeneration.408,409”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [409]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Parkin and PINK1 mitigate STING-induced inflammation
Sliter, D. A., Martinez, J., Hao, L., Chen, X., Sun, N., Fischer, T. D., Burman, J. L., Li, Y., Zhang, Z., Narendra, D. P., et al. (2018) · Nature · doi:10.1038/s41586-018-0448-9 · Cited by 1,287
RetractedFeigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Decout, A., Katz, J. D., Venkatraman, S., & Ablasser, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00524-z · Cited by 2,309
Molecular mechanisms and cellular functions of cGAS–STING signalling
Hopfner, K.-P., & Hornung, V. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0244-x · Cited by 2,052 · cited 9×
“PNAS 2022 Vol. 119 No. 17 e2204058119 https://doi.org/10.1073/pnas.2204058119 1 of 2 COMMENTARY been developed to target the DNA binding site and active site of cGAS as well as to limit STING activation and oligomerization (12).”
BackgroundInfluentialObeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859
Self-citationFanciulli, A., & Wenning, G. K. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1311488 · Cited by 809
CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease
Williams, G. P., Schonhoff, A. M., Jurkuvenaite, A., Gallups, N. J., Standaert, D. G., & Harms, A. S. (2021) · Brain · doi:10.1093/brain/awab103 · Cited by 306
Self-citationSTING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy
Hinkle, J. T., Patel, J., Panicker, N., Karuppagounder, S. S., Biswas, D., Belingon, B., Chen, R., Brahmachari, S., Pletnikova, O., Troncoso, J. C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118819119 · Cited by 240 · cited 4×
“(4) show that activation of cGAS/STING results in microglial up-regulation of proinflammatory chemokines including CXCL10, which is known to promote the trafficking of T cells to the area of inflammation.”
BackgroundInfluentialMitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism
Borsche, M., König, I. R., Delcambre, S., Petrucci, S., Balck, A., Brüggemann, N., Zimprich, A., Wasner, K., Pereira, S. L., Avenali, M., et al. (2020) · Brain · doi:10.1093/brain/awaa246 · Cited by 196 · cited 1×
“Consistent with these observations, in patients biallelic for either Parkin or PINK1 gene mutations there are increased levels of mitochondrial DNA in the serum as well as evidence of inflammation (8).”
BackgroundBido, S., Muggeo, S., Massimino, L., Marzi, M. J., Giannelli, S. G., Melacini, E., Nannoni, M., Gambarè, D., Bellini, E., Ordazzo, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26519-x · Cited by 190 · cited 1×
“Is the phagocytosis of these fibrils causing cellular dysfunction and organelle damage to the microglia? Previous studies have shown that α-syn fibrils cause decreases in microglia phagocytic capacity (14), but there is currently no other evidence that α-syn causes direct damage to microglia.”
Background
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“αsynuclein pathology was found to cause STING-dependent neuroinflammation and dopaminergic neurodegeneration.(408,409) In PINK1 or PRKN deficient mice, mitochondrial stress induces mtDNA accumulation and increases the secretion of cytokines into the bloodstream which can be reversed by STING deletion.”
BackgroundMechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders
Huang, Y., Liu, B., Sinha, S. C., Amin, S., & Gan, L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00672-x · Cited by 164
“In PD, PINK1 and PRKN mutations and αSyn preformed fibril (αSyn-PFF) can induce cGAS activation [24, 49].”
BackgroundMitophagy and cGAS–STING crosstalk in neuroinflammation
Zhou, X., Wang, J., Yu, L., Qiao, G., Qin, D., Yuen-Kwan Law, B., Ren, F., Wu, J., & Wu, A. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.012 · Cited by 131
α-Synuclein pathology as a target in neurodegenerative diseases
Park, H.-J., Kam, T., Dawson, V. L., & Dawson, T. M. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01043-w · Cited by 125
Chung, S., Jeong, J.-H., Park, J.-C., Han, J. W., Lee, Y., Kim, J.-I., & Mook-Jung, I. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01295-y · Cited by 103
“However, increasing evidence implicates dysregulation of the cGAS-STING pathway in neurological disorders, including multiple sclerosis 15 , Parkinson ’ s disease 16 , amyotrophic lateral sclerosis (ALS) 17 , Huntington ’ s disease 18 , and recently, amyloidosis 19 and tauopathy 20 .”
Metadata
- Authors
- Standaert, D. G., & Childers, G. M.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Standaert, David G.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2022-04-21
- Volume
- 119
- Issue
- 17
- Pages
- e2204058119-e2204058119
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC9170025
- OpenAlex
- W4224210637
- Cited by
- 40
- References
- 15
- Citations by year
- 2026: 13 · 2025: 8 · 2024: 10 · 2023: 8 · 2022: 1
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Office of Extramural Research, National Institutes of Health (NS108675)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- alpha-synuclein, DNA damage, STING activation, neuroinflammation, Parkinson's disease, innate immunity, neurodegeneration
- MeSH terms
- Neuroinflammatory Diseases, Animals, Disease Models, Animal, DNA Damage, Parkinson Disease, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alpha-synuclein–mediated DNA damage, STING activation, and neuroinflammation in Parkinson’s disease. https://app.cochat.ai/papers/10.1073/pnas.2204058119
- The paper
- Standaert, D. G., & Childers, G. M. (2022). Alpha-synuclein–mediated DNA damage, STING activation, and neuroinflammation in Parkinson’s disease. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2204058119
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.